Consolidated Statements Of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Consolidated Statements Of Cash Flows [Abstract]
Net income	$ 8,970	$ 12,702
Adjustments to reconcile net income to net cash from operating activities:
Provision for credit losses	5,356	1,442
Depreciation	371	426
Accretion, net	(940)	(671)
Deferred income tax expense (benefit)	6	(97)
Originations of loans held for sale	(31,926)	(8,809)
Proceeds from sale of loans held for sale	28,822	8,119
Net gains on sales of residential mortgage loans	(287)	(85)
Net gains on sales of commercial loans	(167)	(12)
Loss on sale of other assets held for sale		13
Loss on disposal of premises and equipment		60
Earnings on bank owned life insurance	(633)	(462)
Stock-based compensation expense	842	875
Net change in:
Accrued interest receivable and other assets	(1,809)	(3,116)
Operating lease right-of-use asset	581	487
Operating lease liability	(535)	(489)
Accrued interest payable and other liabilities	(7,095)	(312)
Net cash from operating activities	1,556	10,071
Cash flows used by investing activities:
Available-for-sale securities: Maturities, prepayments and calls	1,005	1,510
Available-for-sale securities, Purchases	(1,170)
Loan and lease originations and payments, net	(31,143)	(88,571)
Proceeds from the sale of commercial loans	4,011	361
Additions to premises and equipment	(39)	(648)
Purchase of FRB and FHLB Stock	(426)	(557)
Purchase of other investments		(1,200)
Other adjustments	439	492
Proceeds from the sale of other assets held for sale		1,892
Net cash used by investing activities	(27,323)	(86,721)
Cash flows from financing activities:
Net change in deposits	1,519	157,071
Proceeds from FHLB advances and other debt	27,151	37,060
Repayments on FHLB advances and other debt	(28,500)	(36,560)
Net change in advances by borrowers for taxes and insurance	(965)	(1,776)
Cash dividends paid	(1,161)	(1,090)
Proceeds from exercise of stock options		44
Acquisition of treasury shares surrendered upon vesting of restricted stock for payment of taxes and exercise of stock options for exercise proceeds	(129)	(123)
Purchase of treasury shares	(223)
Net cash (used by) from financing activities	(2,308)	154,626
Net change in cash and cash equivalents	(28,075)	77,976
Beginning cash and cash equivalents	261,595	151,787
Ending cash and cash equivalents	233,520	229,763
Supplemental cash flow information:
Interest paid	54,230	41,018
Income tax paid	358	3,175
Supplemental noncash disclosures:
Investment payable on limited partnerships	6,000	940
Initial recognition of operating lease asset	1,619	4,267
Right-of-use asset obtained in exchange for new operating lease liability	$ 1,619	$ 4,267